Pfizer/Sanofi Exubera Effective For Both Type 1 And Type 2 Diabetes, Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory committee rejects FDA contention that inhaled insulin may not have shown intensive glycemic control in Type 1 diabetes.
You may also be interested in...
Pfizer’s Exubera Launch Now Slated For July
The company had previously said that the inhaled insulin would be available in June; it was approved in January.
Pfizer’s Exubera Launch Now Slated For July
The company had previously said that the inhaled insulin would be available in June; it was approved in January.
Pfizer Breathes Easy: FDA Approves Exubera
Pfizer's Exubera is the first inhaled insulin to clear FDA; labeling recommends lung function testing.